Skip to main content
NCBI home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1990 Jan;152(1):41–45.

The effect of chromium picolinate on serum cholesterol and apolipoprotein fractions in human subjects.

R I Press 1, J Geller 1, G W Evans 1
PMCID: PMC1002252  PMID: 2408233

Abstract

Chromium has been implicated as a cofactor in the maintenance of normal lipid and carbohydrate metabolism. A deficiency of chromium results from diets low in biologically available chromium. Picolinic acid, a metabolite of tryptophan, forms stable complexes with transitional metal ions, which results in an improved bioavailability of the metal ion chromium. To determine whether or not chromium picolinate is effective in humans, 28 volunteer subjects were given either chromium tripicolinate (3.8 micromol [200 micrograms] chromium) or a placebo daily for 42 days in a double-blind crossover study. A 14-day period off capsules was used between treatments. Levels of total cholesterol, low-density lipoprotein (LDL) cholesterol, and apolipoprotein B, the principal protein of the LDL fraction, decreased significantly while the subjects were ingesting chromium picolinate. The concentration of apolipoprotein A-I, the principal protein of the high-density lipoprotein (HDL) fraction, increased substantially during treatment with chromium picolinate. The HDL-cholesterol level was elevated slightly but not significantly during ingestion of chromium picolinate. Only apolipoprotein B, of the variables measured, was altered significantly during supplementation with the placebo. These observations show that chromium picolinate is efficacious in lowering blood lipids in humans.

Full text

PDF
41

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abraham A. S., Sonnenblick M., Eini M., Shemesh O., Batt A. P. The effect of chromium on established atherosclerotic plaques in rabbits. Am J Clin Nutr. 1980 Nov;33(11):2294–2298. doi: 10.1093/ajcn/33.11.2294. [DOI] [PubMed] [Google Scholar]
  2. Albers J. J., Warnick G. R., Wiebe D., King P., Steiner P., Smith L., Breckenridge C., Chow A., Kuba K., Weidman S. Multi-laboratory comparison of three heparin-Mn2+ precipitation procedures for estimating cholesterol in high-density lipoprotein. Clin Chem. 1978 Jun;24(6):853–856. [PubMed] [Google Scholar]
  3. Anderson R. A. Chromium metabolism and its role in disease processes in man. Clin Physiol Biochem. 1986;4(1):31–41. [PubMed] [Google Scholar]
  4. Anderson R. A., Kozlovsky A. S. Chromium intake, absorption and excretion of subjects consuming self-selected diets. Am J Clin Nutr. 1985 Jun;41(6):1177–1183. doi: 10.1093/ajcn/41.6.1177. [DOI] [PubMed] [Google Scholar]
  5. Anderson R. A., Polansky M. M., Bryden N. A., Patterson K. Y., Veillon C., Glinsmann W. H. Effects of chromium supplementation on urinary Cr excretion of human subjects and correlation of Cr excretion with selected clinical parameters. J Nutr. 1983 Feb;113(2):276–281. doi: 10.1093/jn/113.2.276. [DOI] [PubMed] [Google Scholar]
  6. Anderson R. A., Polansky M. M., Bryden N. A., Roginski E. E., Patterson K. Y., Veillon C., Glinsmann W. Urinary chromium excretion of human subjects: effects of chromium supplementation and glucose loading. Am J Clin Nutr. 1982 Dec;36(6):1184–1193. doi: 10.1093/ajcn/36.6.1184. [DOI] [PubMed] [Google Scholar]
  7. Brunzell J. D., Sniderman A. D., Albers J. J., Kwiterovich P. O., Jr Apoproteins B and A-I and coronary artery disease in humans. Arteriosclerosis. 1984 Mar-Apr;4(2):79–83. doi: 10.1161/01.atv.4.2.79. [DOI] [PubMed] [Google Scholar]
  8. Bunker V. W., Lawson M. S., Delves H. T., Clayton B. E. The uptake and excretion of chromium by the elderly. Am J Clin Nutr. 1984 May;39(5):797–802. doi: 10.1093/ajcn/39.5.797. [DOI] [PubMed] [Google Scholar]
  9. Cousins R. J. Regulatory aspects of zinc metabolism in liver and intestine. Nutr Rev. 1979 Apr;37(4):97–103. doi: 10.1111/j.1753-4887.1979.tb02221.x. [DOI] [PubMed] [Google Scholar]
  10. De Backer G., Rosseneu M., Deslypere J. P. Discriminative value of lipids and apoproteins in coronary heart disease. Atherosclerosis. 1982 Apr;42(2-3):197–203. doi: 10.1016/0021-9150(82)90150-2. [DOI] [PubMed] [Google Scholar]
  11. Evans G. W., Johnson P. E. Characterization and quantitation of a zinc-binding ligand in human milk. Pediatr Res. 1980 Jul;14(7):876–880. doi: 10.1203/00006450-198007000-00007. [DOI] [PubMed] [Google Scholar]
  12. Friedewald W. T., Levy R. I., Fredrickson D. S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972 Jun;18(6):499–502. [PubMed] [Google Scholar]
  13. Kozlovsky A. S., Moser P. B., Reiser S., Anderson R. A. Effects of diets high in simple sugars on urinary chromium losses. Metabolism. 1986 Jun;35(6):515–518. doi: 10.1016/0026-0495(86)90007-7. [DOI] [PubMed] [Google Scholar]
  14. Krieger I., Cash R., Evans G. W. Picolinic acid in acrodermatitis enteropathica: evidence for a disorder of tryptophan metabolism. J Pediatr Gastroenterol Nutr. 1984;3(1):62–68. doi: 10.1097/00005176-198401000-00014. [DOI] [PubMed] [Google Scholar]
  15. Kumpulainen J. T., Wolf W. R., Veillon C., Mertz W. Determination of chromium in selected United States diets. J Agric Food Chem. 1979 May-Jun;27(3):490–494. doi: 10.1021/jf60223a036. [DOI] [PubMed] [Google Scholar]
  16. Kwiterovich P. O., Jr, Sniderman A. D. Atherosclerosis and apoproteins B and A-I. Prev Med. 1983 Nov;12(6):815–834. doi: 10.1016/0091-7435(83)90265-7. [DOI] [PubMed] [Google Scholar]
  17. Lithell H., Vessby B., Hellsing K. Changes in glucose tolerance and plasma insulin during lipid-lowering treatment with diet, clofibrate and niceritrol. Atherosclerosis. 1982 Jun;43(2-3):177–184. doi: 10.1016/0021-9150(82)90020-x. [DOI] [PubMed] [Google Scholar]
  18. Maciejko J. J., Holmes D. R., Kottke B. A., Zinsmeister A. R., Dinh D. M., Mao S. J. Apolipoprotein A-I as a marker of angiographically assessed coronary-artery disease. N Engl J Med. 1983 Aug 18;309(7):385–389. doi: 10.1056/NEJM198308183090701. [DOI] [PubMed] [Google Scholar]
  19. Mertz W. Chromium occurrence and function in biological systems. Physiol Rev. 1969 Apr;49(2):163–239. doi: 10.1152/physrev.1969.49.2.163. [DOI] [PubMed] [Google Scholar]
  20. Newman H. A., Leighton R. F., Lanese R. R., Freedland N. A. Serum chromium and angiographically determined coronary artery disease. Clin Chem. 1978 Apr;24(4):541–544. [PubMed] [Google Scholar]
  21. Newman W. P., 3rd, Freedman D. S., Voors A. W., Gard P. D., Srinivasan S. R., Cresanta J. L., Williamson G. D., Webber L. S., Berenson G. S. Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis. The Bogalusa Heart Study. N Engl J Med. 1986 Jan 16;314(3):138–144. doi: 10.1056/NEJM198601163140302. [DOI] [PubMed] [Google Scholar]
  22. Offenbacher E. G., Pi-Sunyer F. X. Beneficial effect of chromium-rich yeast on glucose tolerance and blood lipids in elderly subjects. Diabetes. 1980 Nov;29(11):919–925. doi: 10.2337/diab.29.11.919. [DOI] [PubMed] [Google Scholar]
  23. Riesen W. F., Mordasini R., Salzmann C., Theler A., Gurtner H. P. Apoproteins and lipids as discriminators of severity of coronary heart disease. Atherosclerosis. 1980 Sep;37(1):157–162. doi: 10.1016/0021-9150(80)90104-5. [DOI] [PubMed] [Google Scholar]
  24. Schmidt S. B., Wasserman A. G., Muesing R. A., Schlesselman S. E., Larosa J. C., Ross A. M. Lipoprotein and apolipoprotein levels in angiographically defined coronary atherosclerosis. Am J Cardiol. 1985 Jun 1;55(13 Pt 1):1459–1462. doi: 10.1016/0002-9149(85)90953-1. [DOI] [PubMed] [Google Scholar]
  25. Schroeder H. A., Nason A. P., Tipton I. H. Chromium deficiency as a factor in atherosclerosis. J Chronic Dis. 1970 Aug;23(2):123–142. doi: 10.1016/0021-9681(70)90071-8. [DOI] [PubMed] [Google Scholar]
  26. Schroeder H. A. Serum cholesterol and glucose levels in rats fed refined and less refined sugars and chromium. J Nutr. 1969 Feb;97(2):237–242. doi: 10.1093/jn/97.2.237. [DOI] [PubMed] [Google Scholar]
  27. Sniderman A., Shapiro S., Marpole D., Skinner B., Teng B., Kwiterovich P. O., Jr Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins]. Proc Natl Acad Sci U S A. 1980 Jan;77(1):604–608. doi: 10.1073/pnas.77.1.604. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Votava H. J., Hahn C. J., Evans G. W. Isolation and partial characterization of a 51Cr complex from Brewers' yeast. Biochem Biophys Res Commun. 1973 Nov 16;55(2):312–319. doi: 10.1016/0006-291x(73)91089-9. [DOI] [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES